Hypertension and hepatic steatosis

被引：0
作者：
Matthew J. Brookes
Tariq H. Iqbal
Brian T. Cooper
机构：
[1] City Hospital,Gastroenterology Unit
来源：
Current Hypertension Reports | 2008年 / 10卷
关键词：
Metformin; NASH; Pioglitazone; Hepatic Steatosis; Hepatic Stellate Cell;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Hepatic steatosis (fatty liver) is increasingly recognized as a major component of the metabolic (insulin resistance) syndrome. It can progress to cirrhosis and hepatocellular carcinoma, leading to liver-related mortality. Increasing evidence shows a significant association between hepatic steatosis and hypertension; both are linked to the metabolic syndrome. This review discusses the evidence to support this association, and reviews the diagnosis and management of hepatic steatosis.
引用
收藏
相关论文
共 141 条
[41]  
Zamara E.(2005)Improvement of liver function parameters in patients with type 2 diabetes treated with thiazolidinediones Metabolism 54 529-532
[42]  
Novo E.(2006)Safety and effectiveness of rosiglitazone in type 2 diabetes patients with nonalcoholic fatty liver disease J Formos Med Assoc 105 743-752
[43]  
Marra F.(2007)Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes N Engl J Med 356 2457-2471
[44]  
Cortez-Pinto H.(2006)A pilot study of atorvastatin treatment in dyslipemid, non-alcoholic fatty liver patients Aliment Pharmacol Ther 23 1643-1647
[45]  
de Moura M.C.(2004)Efficacy of omega-3 fatty acids, atorvastatin and orlistat in non-alcoholic fatty liver disease with dyslipidemia Indian J Gastroenterol 23 131-134
[46]  
Day C.P.(2004)Ursodeoxycholic acid for treatment of nonalcoholics steatohepatitis: results of a randomized trial Hepatology 39 770-778
[47]  
Ribeiro P.S.(2006)Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis Clin Gastroenterol Hepatol 4 1537-1543
[48]  
Cortez-Pinto H.(2005)Angiotensin II participates in hepatic inflammation and fibrosis through MCP-1 expression Dig Dis Sci 50 942-948
[49]  
Sola S.(2004)Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis Hepatology 40 1222-1225
[50]  
Arkan M.C.(2007)Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis J Gastroenterol Hepatol 22 634-638
12345678910